deltatrials
Completed PHASE4 INTERVENTIONAL 1-arm NCT02847091

Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy

Post-marketing Clinical Study of Ipragliflozin; Multicenter, Open-label Study to Assess the Efficacy of Ipragliflozin Add-on in Reducing Insulin Dose in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy

Sponsor: Astellas Pharma Inc

Conditions Type 2 Diabetes Mellitus
Interventions Insulin Ipragliflozin
Updated 13 times since 2017 Last updated: Nov 8, 2024 Started: Jul 29, 2016 Primary completion: Nov 9, 2017 Completion: Nov 9, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Type 2 Diabetes Mellitus, this trial is completed. The trial is conducted by Astellas Pharma Inc and has accumulated 13 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshot~Jun 2017 – ~Aug 2017 · 2 months · monthly snapshot~Aug 2017 – ~Dec 2017 · 4 months · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Dec 2018 · 6 months · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Jan 2021 · 24 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Dec 2024 · 3 months · monthly snapshot~Dec 2024 – ~Sep 2025 · 9 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

13 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Dec 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Sep 2024 — Dec 2024 [monthly]

    Completed PHASE4

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  5. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

▶ Show 8 earlier versions

  1. Jan 2019 — Jan 2021 [monthly]

    Completed PHASE4

  2. Dec 2018 — Jan 2019 [monthly]

    Completed PHASE4

  3. Jun 2018 — Dec 2018 [monthly]

    Completed PHASE4

  4. Dec 2017 — Jun 2018 [monthly]

    Completed PHASE4

    Status: Active Not Recruiting → Completed

  5. Aug 2017 — Dec 2017 [monthly]

    Active Not Recruiting PHASE4

    Status: Recruiting → Active Not Recruiting

  6. Jun 2017 — Aug 2017 [monthly]

    Recruiting PHASE4

  7. Feb 2017 — Jun 2017 [monthly]

    Recruiting PHASE4

  8. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE4

    First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Astellas Pharma Inc
Data source: Astellas Pharma Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations